5-Amino-1MQ is not approved by the FDA, EMA, or any other regulatory authority for any indication
Phase Weeks 3+ (standard) Daily dose 100 mg once daily Notes The most common research community target dose
MRM transitions for SAM (RT: 6.1 min) were 399298 (4 V), 399250 (12 V), 39997 (32 V) and 399136 (24 V) for M + 0, and 400299 (4 V), 400251 (12 V), 40097 (32 V), 400137 (24 V), 400250 (12 V) and 400136 (24 V) for M + 1
If you later see a specialist or change providers, you have a clear history of your therapy, which helps guide ongoing care
Results in research may vary
Keep out of reach of children and pets